Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	MPOS	POSD
1	NRAS(0.1%)	exon4,c.437C>T,p.A146V	0.0006743	0.002377	8413|7	2659|8	0.00046	23977|11	1	115252203	115252203	G	A	clustered_events,normal_artifact,orientation,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				43	0.0
1	NRAS(0.1%)	exon4,c.436G>T,p.A146S	0.0007019	0.0004969	8401|9	2639|4	0.00208	23986|50	1	115252204	115252204	C	A	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>T	p.Ala146Ser	missense_variant				34	0.0
1	NRAS(0.0%)	exon2,c.38G>T,p.G13V	0.0002723	0.0003961	10751|3	3417|1	0.00192	31135|60	1	115258744	115258746	C	A	clustered_events,weak_evidence	NRAS	NM_002524.5	2	c.38G>T	p.Gly13Val	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Neoplasm|Melanoma|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Malignant_melanoma_of_skin|Non-Hodgkin_lymphoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome	33	0.0
1	NRAS(0.0%)	exon2,c.37G>T,p.G13C	0.0004986	0.0006184	10741|11	3421|3	0.00296	31313|93	1	115258745	115258746	C	A	clustered_events,weak_evidence	NRAS	NM_002524.5	2	c.37G>T	p.Gly13Cys	missense_variant	Pathogenic		Melanoma	36	0.0
1	NRAS(0.0%)	exon2,c.37G>A,p.G13S	0.0004064	0.0003979	10741|4	3421|0	0.00035	31313|11	1	115258745	115258746	C	T	clustered_events,weak_evidence	NRAS	NM_002524.5	2	c.37G>A	p.Gly13Ser	missense_variant	Likely_pathogenic		Neoplasm_of_stomach	60	0.0
1	NRAS(0.0%)	exon2,c.35G>A,p.G12D	0.0003321	0.0003987	10697|4	3401|0	0.00029	31250|9	1	115258747	115258748	C	T	clustered_events,weak_evidence	NRAS	NM_002524.5	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Epidermal_nevus|Malignant_melanoma_of_skin|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|Myelodysplastic_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|Malignant_neoplasm_of_body_of_uterus|not_provided	31	0.0
1	NRAS(0.0%)	exon2,c.34G>T,p.G12C	0.0001725	0.000404	10615|4	3381|1	0.00217	31323|68	1	115258748	115258748	C	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.34G>T	p.Gly12Cys	missense_variant	Pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome|Malignant_neoplasm_of_body_of_uterus|not_provided	26	0.0
1	NRAS(0.0%)	exon2,c.34G>A,p.G12S	0.0002737	0.0007328	10615|3	3381|1	0.00016	31323|5	1	115258748	115258748	C	T	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|Myelodysplastic_syndrome|Noonan_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|Rasopathy|Malignant_neoplasm_of_body_of_uterus|not_provided	57	0.0
	SPTA1(5.6%)	exon20,c.2898+1G>A	0.056	0.056	75|4	24|0	0.04301	89|4	1	158626353	158626353	C	T	PASS	SPTA1	NM_003126.4	20	c.2898+1G>A		splice_donor_variant&intron_variant				36	0.0
	IKBKE(46.7%)	exon22,c.2138C>T,p.P713L	0.467	0.167	14|11	7|0	0.44000	14|11	1	206669465	206669465	C	T	germline	IKBKE	NM_014002.4	22	c.2138C>T	p.Pro713Leu	missense_variant				46	0.0
	ALK(0.2%)	exon18,c.3031G>T,p.G1011W	0.001941	0.0009935	5753|12	1317|0	0.00343	12204|42	2	29449824	29449824	C	A	PASS	ALK	NM_004304.5	18	c.3031G>T	p.Gly1011Trp	missense_variant				53	0.0
-	MSH2(19.0%)	exon2,c.212-4del	0.19	0.16	329|98	52|13	0.16561	660|131	2	47635523	47635524	CT	C	multiallelic,normal_artifact,panel_of_normals	MSH2	NM_000251.3	1	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_I|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	42	0.0
-	MSH2(10.4%)	exon2,c.212-4dup	0.104	0.1	329|59	52|10	0.14729	660|114	2	47635523	47635524	CT	CTT	multiallelic,normal_artifact,panel_of_normals,suspected_bg	MSH2	NM_000251.3	1	c.212-4dup		splice_region_variant&intron_variant	Benign		Lynch_syndrome_I|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer	45	0.0
-	MSH6(2.9%)	exon4,c.2690del,p.N897fs	0.029	0.017	413|12	78|0	0.02131	551|12	2	48027806	48027807	CA	C	PASS	MSH6	NM_000179.3	4	c.2690del	p.Asn897fs	frameshift_variant	Pathogenic		Hereditary_nonpolyposis_colon_cancer	33	0.0
-	MSH6(4.4%)	exon5,c.3261del,p.F1088fs	0.044	0.036	4766|262	1243|53	0.04114	10046|431	2	48030639	48030640	AC	A	normal_artifact,panel_of_normals,slippage	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Hereditary_nonpolyposis_colorectal_cancer_type_5|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	43	0.0
	STAT4(9.7%)	exon8,c.763C>A,p.L255I	0.097	0.143	36|3	6|0	0.09302	39|4	2	191929552	191929552	G	T	PASS	STAT4	NM_003151.4	8	c.763C>A	p.Leu255Ile	missense_variant				22	0.0
	BMPR2(0.7%)	exon12,c.1748del,p.N583fs	0.007462	0.006566	5310|67	1331|10	0.00920	11200|104	2	203420129	203420130	GA	G	normal_artifact,panel_of_normals	BMPR2	NM_001204.7	12	c.1748del	p.Asn583fs	frameshift_variant	Pathogenic		Pulmonary_arterial_hypertension|Primary_pulmonary_hypertension|Idiopathic_and/or_familial_pulmonary_arterial_hypertension	42	0.0
1	IDH1(0.0%)	exon4,c.395G>T,p.R132L	0.0004024	0.0008055	6197|7	1856|2	0.00319	14383|46	2	209113112	209113112	C	A	base_qual,clustered_events,strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.395G>T	p.Arg132Leu	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome	18	0.0
1	IDH1(0.1%)	exon4,c.394C>T,p.R132C	0.0005974	0.0007122	6160|3	1848|0	0.00066	13613|9	2	209113113	209113113	G	A	clustered_events,orientation,weak_evidence	IDH1	NM_005896.4	4	c.394C>T	p.Arg132Cys	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome|not_provided	12	0.0
1	IDH1(0.0%)	exon4,c.394C>A,p.R132S	0.0004092	0.001736	6160|4	1848|6	0.00256	13613|35	2	209113113	209113113	G	T	clustered_events,orientation,weak_evidence	IDH1	NM_005896.4	4	c.394C>A	p.Arg132Ser	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome	27	0.0
	UGT1A1(1.3%)	exon,c.-55_-54insAT	0.013	0.013	5405|88	1787|39	0.01648	18982|318	2	234668879	234668883	CATAT	CATATAT	clustered_events,multiallelic,normal_artifact,panel_of_normals,suspected_bg	UGT1A1	NM_000463.3		c.-55_-54insAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity,_drug_response,_other	Benign(4),Pathogenic(5)	Gilbert_syndrome|Lucey-Driscoll_syndrome|Crigler-Najjar_syndrome,_type_II|Crigler-Najjar_syndrome_type_1|Bilirubin,_serum_level_of,_quantitative_trait_locus_1|Irinotecan_response|not_specified|not_provided	46	0.0
2	FANCD2(6.4%)	exon6,c.378-5del	0.064	0.05	564|44	97|5	0.06736	803|58	3	10076842	10076843	CT	C	multiallelic,normal_artifact,panel_of_normals,slippage	FANCD2	NM_033084.6	5	c.378-5del		splice_region_variant&intron_variant				41	0.0
2	FANCD2(5.8%)	exon6,c.378-5dup	0.058	0.051	564|41	97|4	0.07060	803|61	3	10076842	10076843	CT	CTT	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	FANCD2	NM_033084.6	5	c.378-5dup		splice_region_variant&intron_variant				41	0.0
	TGFBR2(9.1%)	exon4,c.458del,p.K153fs	0.091	0.089	581|71	141|14	0.08227	937|84	3	30691871	30691873	GAA	GA	multiallelic,normal_artifact,panel_of_normals	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Benign(3),Likely_benign(1),Likely_pathogenic(1)	Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Cardiovascular_phenotype|not_provided	39	0.0
	ANO10(3.2%)	exon2,c.132del,p.D45fs	0.032	0.047	3090|126	733|40	0.03794	7226|285	3	43647212	43647213	CT	C	multiallelic,normal_artifact,panel_of_normals,slippage	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided	48	0.0
	ANO10(2.6%)	exon2,c.132dup,p.D45fs	0.026	0.012	3090|108	733|12	0.03253	7226|243	3	43647212	43647213	CT	CTT	multiallelic,normal_artifact,panel_of_normals,slippage,background	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Abnormal_central_motor_function|Spinocerebellar_ataxia,_autosomal_recessive_10|Autosomal_recessive_cerebellar_ataxia|not_provided	52	0.0
	PBRM1(7.3%)	exon14,c.1473C>T,p.D491=	0.073	0.125	56|4	7|0	0.05970	63|4	3	52661357	52661357	G	A	PASS	PBRM1	NM_018313.5	14	c.1473C>T	p.Asp491=	synonymous_variant				46	0.0
	PIK3CB(2.1%)	exon5,c.513G>A,p.W171*	0.021	0.022	332|8	56|0	0.02025	387|8	3	138461508	138461508	C	T	distinguished	PIK3CB	NM_006219.3	5	c.513G>A	p.Trp171*	stop_gained				47	0.0
	ATR(5.7%)	exon10,c.2320del,p.I774fs	0.057	0.041	4700|374	1319|62	0.05802	10682|658	3	142274739	142274740	AT	A	multiallelic,normal_artifact,panel_of_normals,slippage	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided	41	0.0
	ATR(3.3%)	exon10,c.2320dup,p.I774fs	0.033	0.035	4700|217	1319|66	0.05125	10682|577	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic		not_provided	41	0.0
1	PIK3CA(0.1%)	exon21,c.3139C>T,p.H1047Y	0.0005707	0.000495	6110|4	2650|0	0.00033	17934|6	3	178952084	178952085	C	T	clustered_events,weak_evidence	PIK3CA	NM_006218.4	21	c.3139C>T	p.His1047Tyr	missense_variant	Pathogenic		Segmental_undergrowth_associated_with_mainly_venous_malformation_with_capillary_component|Hepatocellular_carcinoma|Medulloblastoma|Adrenocortical_carcinoma|Congenital_macrodactylia|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Epidermal_nevus|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Adenocarcinoma_of_prostate|Lung_carcinoma|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Cowden_syndrome_5|Cowden_syndrome|Familial_cancer_of_breast|Glioblastoma|Malignant_tumor_of_floor_of_mouth|Malignant_neoplasm_of_body_of_uterus|not_provided	35	0.0
1	PIK3CA(0.1%)	exon21,c.3140A>G,p.H1047R	0.0006985	0.0005008	6071|4	2621|0	0.00028	18058|5	3	178952085	178952085	A	G	clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	21	c.3140A>G	p.His1047Arg	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|MACRODACTYLY,_SOMATIC|Segmental_undergrowth_associated_with_lymphatic_malformation|Segmental_undergrowth_associated_with_mainly_venous_malformation_with_capillary_component|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Neoplasm|Medulloblastoma|Adrenocortical_carcinoma|Congenital_macrodactylia|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Rosette-forming_glioneuronal_tumor|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Breast_adenocarcinoma|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Brain_malformation|Familial_cancer_of_breast|Glioblastoma|Lip_and_oral_cavity_carcinoma|Malignant_neoplasm_of_body_of_uterus|OVARIAN_CANCER,_EPITHELIAL,_SOMATIC|PIK3CA_related_overgrowth_spectrum|not_provided	29	0.0
1	PIK3CA(0.0%)	exon21,c.3141T>A,p.H1047Q	0.0004716	0.0008226	6048|5	2607|2	0.00106	17974|19	3	178952086	178952086	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	21	c.3141T>A	p.His1047Gln	missense_variant	Likely_pathogenic		Hepatocellular_carcinoma|Medulloblastoma|Adrenocortical_carcinoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma	14	0.0
	FGFR3(2.1%)	exon15,c.2002_2008delinsTACGTTT,p.D668_V670>YVF	0.021	0.017	478|7	63|0	0.02584	641|17	4	1808026	1808032	GACCGAG	TACGTTT	clustered_events,haplotype,orientation,panel_of_normals,strand_bias,suspected_bg	FGFR3	NM_000142.5	15	c.2002_2008delinsTACGTTT	p.Asp668_Val670delinsTyrValPhe	missense_variant				27	0.0
	KIT(0.0%)	exon11,c.1669T>G,p.W557G	0.0003888	0.0005983	6380|6	2162|1	0.00160	16218|26	4	55593603	55593603	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1669T>G	p.Trp557Gly	missense_variant	Likely_pathogenic		Gastrointestinal_stroma_tumor	15	0.0
1	KIT(0.0%)	exon11,c.1676T>G,p.V559G	0.0004556	0.0006265	6357|19	2120|6	0.00582	16071|94	4	55593610	55593610	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>G	p.Val559Gly	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stroma_tumor	34	0.0
1	KIT(0.0%)	exon11,c.1676T>A,p.V559D	0.0002241	0.0006105	6357|3	2120|0	0.00149	16071|24	4	55593610	55593610	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>A	p.Val559Asp	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stroma_tumor	38	0.0
1	KIT(0.1%)	exon17,c.2459A>T,p.D820V	0.0005039	0.0009323	5218|3	1463|0	0.00126	15015|19	4	55599333	55599333	A	T	base_qual,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	17	c.2459A>T	p.Asp820Val	missense_variant	Likely_pathogenic		Systemic_mast_cell_disease	34	0.0
	SDHA(59.7%)	exon14,c.1886A>T,p.Y629F	0.597	0.125	11|18	8|0	0.66667	11|22	5	254599	254599	A	T	germline	SDHA	NM_004168.4	14	c.1886A>T	p.Tyr629Phe	missense_variant	Benign/Likely_benign		Leigh_syndrome|Paragangliomas_5|Hereditary_cancer-predisposing_syndrome|Hereditary_Paraganglioma-Pheochromocytoma_Syndromes|Mitochondrial_complex_II_deficiency,_nuclear_type_1|not_specified|not_provided	25	0.0
	SDHA(10.3%)	exon15,c.1974G>C,p.P658=	0.103	0.048	135|15	28|1	0.11446	147|19	5	256514	256514	G	C	clustered_events,panel_of_normals,background	SDHA	NM_004168.4	15	c.1974G>C	p.Pro658=	synonymous_variant	Benign/Likely_benign		Leigh_syndrome|Paragangliomas_5|Hereditary_cancer-predisposing_syndrome|Hereditary_Paraganglioma-Pheochromocytoma_Syndromes|Mitochondrial_complex_II_deficiency,_nuclear_type_1|not_specified|not_provided	28	0.0
	MSH3(1.2%)	exon7,c.1148del,p.K383fs	0.012	0.00833	3657|68	1429|25	0.01543	8232|129	5	79970914	79970915	CA	C	multiallelic,normal_artifact,panel_of_normals,slippage	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|not_provided	46	0.0
	MSH3(1.7%)	exon7,c.1148dup,p.N385fs	0.017	0.026	3657|80	1429|44	0.02035	8232|171	5	79970914	79970915	CA	CAA	multiallelic,normal_artifact,panel_of_normals,slippage	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided	44	0.0
-	APC(25.7%)	exon7,c.646C>T,p.R216*	0.257	0.012	204|69	111|0	0.25000	255|85	5	112128143	112128143	C	T	PASS	APC	NM_000038.6	7	c.646C>T	p.Arg216*	stop_gained&splice_region_variant	Pathogenic		Hepatocellular_carcinoma|Neoplasm_of_stomach|Carcinoma_of_colon|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|Desmoid_disease,_hereditary|not_provided	28	0.0
	RAD50(5.6%)	exon13,c.2165del,p.K722fs	0.056	0.042	3695|258	1475|78	0.05029	10178|539	5	131931451	131931452	TA	T	multiallelic,normal_artifact,panel_of_normals,slippage	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome	45	0.0
	RAD50(1.4%)	exon13,c.2165dup,p.E723fs	0.014	0.017	3695|74	1475|34	0.02956	10178|310	5	131931451	131931452	TA	TAA	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided	47	0.0
	EPHA7(1.4%)	exon16,c.2833A>G,p.T945A	0.014	0.008834	407|6	125|0	0.01246	555|7	6	93955065	93955065	T	C	PASS	EPHA7	NM_004440.4	16	c.2833A>G	p.Thr945Ala	missense_variant				25	0.0
	GRIK2(2.8%)	exon16,c.2546dup,p.N849fs	0.028	0.00847	1072|35	292|2	0.03121	1614|52	6	102503431	102503432	CA	CAA	multiallelic,panel_of_normals,slippage,suspected_bg	GRIK2	NM_021956.5	16	c.2546dup	p.Asn849fs	frameshift_variant				51	0.0
	PRDM1(26.0%)	exon3,c.349A>T,p.I117L	0.26	0.063	83|26	19|0	0.26316	98|35	6	106543547	106543547	A	T	PASS	PRDM1	NM_001198.4	3	c.349A>T	p.Ile117Leu	missense_variant				29	0.0
	PMS2(14.0%)	exon14,c.2324A>G,p.N775S	0.14	0.145	86|8	7|0	0.09434	96|10	7	6017340	6017340	T	C	PASS	PMS2	NM_000535.7	14	c.2324A>G	p.Asn775Ser	missense_variant	Benign		Endometrial_carcinoma|Lynch_syndrome|Lynch_syndrome_I|Turcot_syndrome|Hereditary_nonpolyposis_colorectal_cancer_type_4|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|Breast_and/or_ovarian_cancer|not_provided	27	0.0
2	PMS2(25.8%)	exon7,c.706-5_706-4del	0.258	0.141	158|156	15|9	0.16836	1146|232	7	6037057	6037059	GAA	G	germline,multiallelic,normal_artifact,panel_of_normals	PMS2	NM_000535.7	6	c.706-5_706-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome|Hereditary_nonpolyposis_colorectal_cancer_type_4|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified	48	0.0
2	PMS2(34.9%)	exon7,c.706-4del	0.349	0.366	158|190	15|17	0.25196	1146|386	7	6037057	6037059	GAA	GA	germline,multiallelic,normal_artifact,panel_of_normals	PMS2	NM_000535.7	6	c.706-4del		splice_region_variant&intron_variant	Benign		Neoplasm_of_ovary|Lynch_syndrome|Hereditary_nonpolyposis_colorectal_cancer_type_4|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|Breast_and/or_ovarian_cancer|not_provided	44	0.0
	INHBA(20.4%)	exon2,c.257C>T,p.A86V	0.204	0.001455	7370|1875	2686|2	0.20461	20358|5237	7	41739716	41739716	G	A	PASS	INHBA	NM_002192.4	2	c.257C>T	p.Ala86Val	missense_variant				43	0.0
1	EGFR(0.1%)	exon18,c.2125G>C,p.E709Q	0.0006444	0.001484	4623|4	924|0	0.00090	8900|8	7	55241677	55241679	G	C	base_qual,clustered_events,weak_evidence	EGFR	NM_005228.5	18	c.2125G>C	p.Glu709Gln	missense_variant				28	0.0
1	EGFR(0.1%)	exon18,c.2155G>T,p.G719C	0.0009758	0.001876	3351|5	667|0	0.00239	6252|15	7	55241707	55241707	G	T	base_qual,clustered_events,orientation,weak_evidence	EGFR	NM_005228.5	18	c.2155G>T	p.Gly719Cys	missense_variant	Pathogenic/Likely_pathogenic,_drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Glioblastoma|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic	16	0.0
1	EGFR(0.1%)	exon18,c.2156G>A,p.G719D	0.001132	0.001893	3277|3	648|0	0.00098	6113|6	7	55241708	55241708	G	A	clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2156G>A	p.Gly719Asp	missense_variant	Likely_pathogenic		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Glioblastoma	32	0.0
1	EGFR(0.0%)	exon19,c.2236_2250del,p.E746_A750del	0.0001641	0.0008091	8718|1	1680|0	0.00000	18036|0	7	55242465	55242480	GGAATTAAGAGAAGCA	G	clustered_events,weak_evidence	EGFR	NM_005228.5	19	c.2236_2250del	p.Glu746_Ala750del	conservative_inframe_deletion	Pathogenic		Tyrosine_kinase_inhibitor_response|not_provided	1	0.0
1	EGFR(0.1%)	exon20,c.2369C>T,p.T790M	0.001072	0.003442	4199|4	783|2	0.00054	7452|4	7	55249071	55249071	C	T	clustered_events,normal_artifact,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2369C>T	p.Thr790Met	missense_variant	drug_response		Non-small_cell_lung_carcinoma|Lung_carcinoma|Lung_cancer|Hereditary_cancer-predisposing_syndrome|Nonsmall_cell_lung_cancer,_resistance_to_tyrosine_kinase_inhibitor_in|EGFR-related_lung_cancer|Tyrosine_kinase_inhibitor_response|erlotinib_response_-_Efficacy|gefitinib_response_-_Efficacy|not_provided	61	0.0
1	EGFR(0.1%)	exon20,c.2386G>A,p.G796S	0.001035	0.001768	4138|3	758|0	0.00068	7295|5	7	55249088	55249088	G	A	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2386G>A	p.Gly796Ser	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1),Uncertain_significance(1)	EGFR-related_lung_cancer|not_provided	51	0.0
1	EGFR(0.1%)	exon20,c.2387G>A,p.G796D	0.0008926	0.001775	4116|3	757|0	0.00120	7481|9	7	55249089	55249089	G	A	clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2387G>A	p.Gly796Asp	missense_variant				56	0.0
1	EGFR(0.0%)	exon21,c.2573T>G,p.L858R	0.0004391	0.002116	3587|3	677|2	0.00142	6314|9	7	55259515	55259515	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2573T>G	p.Leu858Arg	missense_variant	drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Lung_carcinoma|Adenocarcinoma_of_lung,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Erlotinib_response|Gefitinib_response|Tyrosine_kinase_inhibitor_response|gefitinib_response_-_Efficacy	17	0.0
1	MET(0.0%)	exon14,c.2888-1G>A	0.0004174	0.0005763	8639|3	2173|0	0.00048	26949|13	7	116411902	116411902	G	A	orientation,weak_evidence	MET	NM_000245.4	13	c.2888-1G>A		splice_acceptor_variant&intron_variant				70	0.0
1	MET(0.0%)	exon14,c.3007T>A,p.Y1003N	0.0002674	0.001207	8758|3	2227|2	0.00076	32730|25	7	116412022	116412022	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3007T>A	p.Tyr1003Asn	missense_variant				23	0.0
1	MET(0.0%)	exon14,c.3008A>G,p.Y1003C	0.0004632	0.001205	8834|4	2250|2	0.00057	33137|19	7	116412023	116412023	A	G	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3008A>G	p.Tyr1003Cys	missense_variant				24	0.0
1	MET(0.0%)	exon14,c.3008A>T,p.Y1003F	0.0002801	0.0006248	8834|5	2250|3	0.00109	33137|36	7	116412023	116412023	A	T	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3008A>T	p.Tyr1003Phe	missense_variant				50	0.0
1	MET(0.0%)	exon14,c.3028G>T,p.D1010Y	0.0001646	0.001201	8891|6	2300|7	0.00467	33448|157	7	116412043	116412043	G	T	clustered_events,normal_artifact,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>T	p.Asp1010Tyr	missense_variant&splice_region_variant				27	0.0
1	MET(0.1%)	exon14,c.3028+1G>A	0.001136	0.001017	8890|11	2305|1	0.00107	33536|36	7	116412044	116412044	G	A	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided	58	0.0
1	MET(0.0%)	exon14,c.3028+2T>C	0.000445	0.0005952	8801|3	2285|0	0.00060	33189|20	7	116412045	116412045	T	C	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+2T>C		splice_donor_variant&intron_variant	not_provided		not_provided	65	0.0
1	MET(0.0%)	exon14,c.3028+3A>G	0.0004467	0.001098	8736|3	2265|1	0.00027	32931|9	7	116412046	116412046	A	G	clustered_events,orientation,weak_evidence	MET	NM_000245.4	14	c.3028+3A>G		splice_region_variant&intron_variant				26	0.0
0	BRAF(0.0%)	exon15,c.1799T>G,p.V600G	0.0002362	0.0007296	6202|5	1865|0	0.00191	16725|32	7	140453136	140453137	A	C	base_qual,clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1799T>G	p.Val600Gly	missense_variant	Pathogenic		Melanoma|Cardio-facio-cutaneous_syndrome|Rasopathy|not_provided	47	0.0
1	BRAF(0.0%)	exon15,c.1799T>A,p.V600E	0.0004878	0.0007296	6202|6	1865|0	0.00143	16725|24	7	140453136	140453137	A	T	base_qual,clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1799T>A	p.Val600Glu	missense_variant	Pathogenic,_drug_response,_other		Cystic_epithelial_invagination_containing_papillae_lined_by_columnar_epithelium|Trametinib-Dabrafenib_Response|Vemurafenib-Cobimetinib_Response|Nephroblastoma|Cerebral_arteriovenous_malformation|Neoplasm|Melanoma|Papillary_thyroid_carcinoma|Multiple_myeloma|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Colonic_neoplasm|Neoplasm_of_ovary|Gastrointestinal_stroma_tumor|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Malignant_neoplastic_disease|Lung_carcinoma|Malignant_Colorectal_Neoplasm|Squamous_cell_carcinoma_of_the_head_and_neck|Cardio-facio-cutaneous_syndrome|Glioblastoma|Germ_cell_tumor,_nonseminomatous|Papillary_renal_cell_carcinoma,_sporadic|Astrocytoma,_low-grade,_somatic|not_provided	33	0.0
1	BRAF(0.1%)	exon15,c.1798G>A,p.V600M	0.0008385	0.001316	6210|5	1861|2	0.00054	16804|9	7	140453137	140453137	C	T	clustered_events,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1798G>A	p.Val600Met	missense_variant	Likely_pathogenic		Melanoma|Non-small_cell_lung_carcinoma|not_provided	22	0.0
	BRAF(0.1%)	exon15,c.1796C>T,p.T599I	0.0007231	0.001337	6150|4	1843|1	0.00054	16613|9	7	140453139	140453139	G	A	clustered_events,orientation,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1796C>T	p.Thr599Ile	missense_variant	Pathogenic		Neoplasm|Melanoma|Cardiofaciocutaneous_syndrome_1|Noonan_syndrome|Rasopathy|not_provided	11	0.0
-	KMT2C(1.9%)	exon38,c.8390dup,p.E2798fs	0.019	0.024	9003|242	2382|74	0.04156	26151|1134	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,panel_of_normals,suspected_bg	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided	43	0.0
	KMT2C(15.0%)	exon16,c.2763A>G,p.L921=	0.15	0.1	42|5	12|0	0.14062	55|9	7	151932908	151932908	T	C	clustered_events,panel_of_normals,suspected_bg	KMT2C	NM_170606.3	16	c.2763A>G	p.Leu921=	synonymous_variant				47	0.0
	KMT2C(13.1%)	exon16,c.2726G>A,p.R909K	0.131	0.097	65|6	12|0	0.08791	83|8	7	151932945	151932945	C	T	clustered_events,suspected_bg	KMT2C	NM_170606.3	16	c.2726G>A	p.Arg909Lys	missense_variant				41	0.0
	KMT2C(10.2%)	exon16,c.2706G>A,p.S902=	0.102	0.091	69|4	15|0	0.06383	88|6	7	151932965	151932965	C	T	clustered_events,suspected_bg	KMT2C	NM_170606.3	16	c.2706G>A	p.Ser902=	synonymous_variant				44	0.0
	NOTCH1(1.5%)	exon34,c.6311G>A,p.R2104H	0.015	0.012	914|13	117|0	0.00951	1354|13	9	139391880	139391880	C	T	suspected_bg	NOTCH1	NM_017617.5	34	c.6311G>A	p.Arg2104His	missense_variant	Uncertain_significance		Adams-Oliver_syndrome_5	46	0.0
	SKIDA1(7.6%)	exon4,c.1269_1272delinsAGAGGAG,p.E424dup	0.076	0.034	100|8	24|0	0.60519	152|233	10	21805480	21805483	TTCC	CTCCTCT	haplotype,panel_of_normals,background	SKIDA1	NM_207371.4	4	c.1269_1272delinsAGAGGAG	p.Glu424dup	disruptive_inframe_insertion&synonymous_variant				49	0.0
1	RET(0.0%)	exon11,c.1902C>G,p.C634W	0.0004806	0.0008419	5868|3	1500|0	0.00160	16886|27	10	43609950	43609950	C	G	clustered_events,strand_bias,weak_evidence	RET	NM_020975.6	11	c.1902C>G	p.Cys634Trp	missense_variant	Pathogenic		Pheochromocytoma|Medullary_thyroid_carcinoma|Neoplasm_of_the_thyroid_gland|Multiple_endocrine_neoplasia,_type_1|Multiple_endocrine_neoplasia,_type_2b|Multiple_endocrine_neoplasia,_type_2a|Multiple_endocrine_neoplasia,_type_4|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|not_provided	36	0.0
1	RET(0.0%)	exon16,c.2753T>C,p.M918T	0.0002337	0.0003871	13455|3	3642|0	0.00010	57839|6	10	43617416	43617416	T	C	orientation,strand_bias,weak_evidence	RET	NM_020975.6	16	c.2753T>C	p.Met918Thr	missense_variant	Pathogenic/Likely_pathogenic		Gingival_overgrowth|Hypertelorism|Hypothyroidism|Joint_hypermobility|Short_stature|Tetralogy_of_Fallot|Constipation|Pheochromocytoma|Medullary_thyroid_carcinoma|Thick_vermilion_border|Neoplasm_of_the_thyroid_gland|Multiple_endocrine_neoplasia,_type_1|Hirschsprung_disease_1|Familial_medullary_thyroid_carcinoma|Multiple_endocrine_neoplasia,_type_2b|Multiple_endocrine_neoplasia,_type_2a|Multiple_endocrine_neoplasia,_type_4|Multiple_endocrine_neoplasia,_type_2|Inborn_genetic_diseases|Thyroid_carcinoma,_sporadic_medullary|not_specified|not_provided	25	0.0
-	PTEN(5.8%)	exon8,c.802-4_802-3del	0.058	0.064	89|19	31|5	0.08090	409|36	10	89720633	89720635	CTT	C	germline,multiallelic,normal_artifact,panel_of_normals	PTEN	NM_000314.8	7	c.802-4_802-3del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	39	0.0
-	PTEN(19.3%)	exon8,c.802-3del	0.193	0.174	89|46	31|18	0.23120	409|123	10	89720633	89720635	CTT	CT	germline,multiallelic,normal_artifact,panel_of_normals	PTEN	NM_000314.8	7	c.802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided	28	0.0
-	PTEN(25.1%)	exon8,c.802-3dup	0.251	0.296	89|54	31|24	0.24259	409|131	10	89720633	89720635	CTT	CTTT	germline,multiallelic,normal_artifact,panel_of_normals,suspected_bg	PTEN	NM_000314.8	7	c.802-3dup		splice_acceptor_variant&intron_variant	Benign		PTEN_hamartoma_tumor_syndrome|not_specified|not_provided	41	0.0
	IFITM3(4.3%)	exon1,c.208C>A,p.P70T	0.043	0.018	399|19	72|0	0.06018	531|34	11	320606	320606	G	T	background	IFITM3	NM_021034.3	1	c.208C>A	p.Pro70Thr	missense_variant				39	0.0
	IFITM3(4.4%)	exon1,c.165C>T,p.P55=	0.044	0.021	386|19	63|0	0.07157	480|37	11	320649	320649	G	A	panel_of_normals,background	IFITM3	NM_021034.3	1	c.165C>T	p.Pro55=	synonymous_variant				63	0.0
	FANCF(4.5%)	exon1,c.47C>T,p.A16V	0.045	0.046	121|4	27|0	0.02703	144|4	11	22647310	22647310	G	A	suspected_bg	FANCF	NM_022725.4	1	c.47C>T	p.Ala16Val	missense_variant				50	0.0
-	ATM(23.1%)	exon6,c.497-4del	0.231	0.252	107|40	34|14	0.22910	249|74	11	108114661	108114662	AT	A	germline,multiallelic,normal_artifact,panel_of_normals	ATM	NM_000051.4	5	c.497-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_specified|not_provided	41	0.0
-	ATM(13.1%)	exon6,c.497-4dup	0.131	0.097	107|30	34|6	0.18893	249|58	11	108114661	108114662	AT	ATT	germline,multiallelic,normal_artifact,panel_of_normals,suspected_bg	ATM	NM_000051.4	5	c.497-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	41	0.0
	CD3G(4.5%)	exon3,c.213del,p.K71fs	0.045	0.048	2251|120	453|23	0.04217	3861|170	11	118220582	118220583	TA	T	multiallelic,normal_artifact,panel_of_normals,slippage	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1),Uncertain_significance(1)	Immunodeficiency_17	45	0.0
	CD3G(1.9%)	exon3,c.213dup,p.W72fs	0.019	0.014	2251|61	453|10	0.02892	3861|115	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic		Immunodeficiency_17	39	0.0
	KDM5A(1.5%)	exon20,c.3035A>G,p.Q1012R	0.015	0.021	386|5	62|0	0.01094	452|5	12	422223	422223	T	C	PASS	KDM5A	NM_001042603.3	20	c.3035A>G	p.Gln1012Arg	missense_variant&splice_region_variant				24	0.0
1	KRAS(0.1%)	exon4,c.437C>T,p.A146V	0.0008844	0.000785	5150|3	1848|0	0.00034	17630|6	12	25378561	25378562	G	A	orientation,weak_evidence	KRAS	NM_033360.4	4	c.437C>T	p.Ala146Val	missense_variant	Pathogenic		OCULOECTODERMAL_SYNDROME,_SOMATIC|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	11	0.0
1	KRAS(0.1%)	exon4,c.436G>C,p.A146P	0.0005818	0.0007745	5185|4	1852|1	0.00034	17819|6	12	25378562	25378562	C	G	orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	4	c.436G>C	p.Ala146Pro	missense_variant	Pathogenic/Likely_pathogenic		Multiple_myeloma|Neoplasm_of_the_large_intestine	1	0.0
1	KRAS(0.1%)	exon3,c.176C>A,p.A59E	0.0005329	0.001031	5991|5	2411|3	0.00126	19787|25	12	25380282	25380282	G	T	clustered_events,weak_evidence	KRAS	NM_033360.4	3	c.176C>A	p.Ala59Glu	missense_variant				28	0.0
1	KRAS(0.1%)	exon3,c.175G>T,p.A59S	0.000615	0.001202	5956|3	2397|2	0.00163	19658|32	12	25380283	25380283	C	A	clustered_events,normal_artifact,weak_evidence	KRAS	NM_033360.4	3	c.175G>T	p.Ala59Ser	missense_variant	Pathogenic/Likely_pathogenic		not_provided	12	0.0
1	KRAS(0.1%)	exon3,c.175G>A,p.A59T	0.0007796	0.00292	5956|5	2397|6	0.00097	19658|19	12	25380283	25380283	C	T	clustered_events,normal_artifact,weak_evidence	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic	37	0.0
1	KRAS(0.0%)	exon2,c.38G>A,p.G13D	0.000469	0.0005292	7443|3	2584|0	0.00041	21792|9	12	25398281	25398282	C	T	clustered_events,weak_evidence	KRAS	NM_033360.4	2	c.38G>A	p.Gly13Asp	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(4),Uncertain_significance(1)	OCULOECTODERMAL_SYNDROME,_SOMATIC|Acute_myeloid_leukemia|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Breast_adenocarcinoma|RAS-associated_autoimmune_leukoproliferative_disorder|Noonan_syndrome_and_Noonan-related_syndrome|Inborn_genetic_diseases|not_provided	53	0.0
1	KRAS(0.1%)	exon2,c.37G>A,p.G13S	0.0005023	0.001062	7450|3	2582|2	0.00064	21941|14	12	25398282	25398282	C	T	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.37G>A	p.Gly13Ser	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	23	0.0
1	KRAS(0.1%)	exon2,c.35G>T,p.G12V	0.0007373	0.0005957	7425|7	2569|4	0.00169	21814|37	12	25398284	25398285	C	A	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	2	c.35G>T	p.Gly12Val	missense_variant	Pathogenic		Acute_myeloid_leukemia|Cerebral_arteriovenous_malformation|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Carcinoma_of_pancreas|not_provided	46	0.0
1	KRAS(0.1%)	exon2,c.35G>A,p.G12D	0.0005305	0.0005352	7425|4	2569|0	0.00027	21814|6	12	25398284	25398285	C	T	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic		Vascular_Tumors_Including_Pyogenic_Granuloma|Acute_myeloid_leukemia|Cerebral_arteriovenous_malformation|Neoplasm_of_stomach|Nevus_sebaceous|Epidermal_nevus|Linear_sebaceous_nevus_sequence|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Carcinoma_of_pancreas|RAS-associated_autoimmune_leukoproliferative_disorder|Capillary_malformation-arteriovenous_malformation_1|Rasopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|not_provided	31	0.0
1	KRAS(0.1%)	exon2,c.34G>A,p.G12S	0.0009321	0.001048	7433|6	2571|2	0.00055	21941|12	12	25398285	25398285	C	T	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Stomach_cancer|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|not_provided	56	0.0
	FAM186A(7.1%)	exon4,c.4793_4811del,p.E1598fs	0.071	0.066	84|3	13|0	0.00000	62|0	12	50745803	50745822	GGTGAGAGGGATCCCCAGTT	G	haplotype,panel_of_normals	FAM186A	NM_001145475.3	4	c.4793_4811del	p.Glu1598fs	frameshift_variant				18	0.0
	FAM186A(17.6%)	exon4,c.4788G>C,p.A1596=	0.176	0.074	34|5	9|0	0.26897	106|39	12	50745827	50745827	C	G	haplotype,panel_of_normals,background	FAM186A	NM_001145475.3	4	c.4788G>C	p.Ala1596=	synonymous_variant				23	0.0
-	HNF1A(3.5%)	exon4,c.872del,p.P291fs	0.035	0.093	193|6	29|2	0.02509	272|7	12	121432117	121432118	GC	G	multiallelic,panel_of_normals,slippage,weak_evidence	HNF1A	NM_000545.8	4	c.872del	p.Pro291fs	frameshift_variant	Pathogenic		Monogenic_diabetes|not_provided	32	0.0
-	HNF1A(4.3%)	exon4,c.872dup,p.G292fs	0.043	0.032	193|6	29|0	0.02158	272|6	12	121432117	121432118	GC	GCC	multiallelic,panel_of_normals,slippage,weak_evidence	HNF1A	NM_000545.8	4	c.872dup	p.Gly292fs	frameshift_variant	Pathogenic		Maturity_onset_diabetes_mellitus_in_young|Clear_cell_carcinoma_of_kidney|Diabetes_mellitus_type_1|Hepatic_adenomas,_familial|Maturity-onset_diabetes_of_the_young,_type_3|Diabetes_mellitus,_insulin-dependent,_20|not_provided	51	0.0
	CDK8(2.5%)	exon12,c.1129_1131del,p.Q377del	0.025	0.02	394|11	51|0	0.02003	587|12	13	26975608	26975611	CCAG	C	panel_of_normals,slippage,background	CDK8	NM_001260.3	12	c.1129_1131del	p.Gln377del	conservative_inframe_deletion				40	0.0
-	BRCA2(2.4%)	exon10,c.1813del,p.I605fs	0.024	0.021	1820|55	385|11	0.02628	3075|83	13	32907420	32907421	GA	G	normal_artifact,panel_of_normals,slippage	BRCA2	NM_000059.4	10	c.1813del	p.Ile605fs	frameshift_variant	Pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Fanconi_anemia,_complementation_group_D1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|not_provided	32	0.0
-	BRCA2(0.8%)	exon23,c.9097del,p.T3033fs	0.008009	0.011	1563|14	260|2	0.00889	2341|21	13	32954022	32954023	CA	C	multiallelic,normal_artifact,panel_of_normals,slippage,weak_evidence	BRCA2	NM_000059.4	23	c.9097del	p.Thr3033fs	frameshift_variant	Pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided	26	0.0
-	BRCA2(1.2%)	exon23,c.9097dup,p.T3033fs	0.012	0.018	1563|23	260|5	0.01556	2341|37	13	32954022	32954023	CA	CAA	multiallelic,normal_artifact,panel_of_normals,slippage,weak_evidence	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Breast_carcinoma|Neoplasm_of_ovary|Hereditary_breast_and_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial_1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided	44	0.0
-	RB1(2.3%)	exon7,c.608-4del	0.023	0.024	5814|179	1275|43	0.02563	18515|487	13	48934140	48934141	AT	A	multiallelic,normal_artifact,panel_of_normals,slippage	RB1	NM_000321.3	6	c.608-4del		splice_region_variant&intron_variant	Likely_benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome|not_provided	41	0.0
-	RB1(3.3%)	exon7,c.608-4dup	0.033	0.036	5814|241	1275|56	0.04709	18515|915	13	48934140	48934141	AT	ATT	multiallelic,normal_artifact,panel_of_normals,slippage	RB1	NM_000321.3	6	c.608-4dup		splice_region_variant&intron_variant				40	0.0
-	RB1(0.2%)	exon7,c.608-3C>T	0.002215	0.005099	6809|20	1489|7	0.00317	21991|70	13	48934150	48934150	C	T	normal_artifact,panel_of_normals	RB1	NM_000321.3	6	c.608-3C>T		splice_region_variant&intron_variant				44	0.0
	RB1(30.5%)	exon18,c.1792A>T,p.N598Y	0.305	0.001922	3131|1318	722|0	0.28761	7396|2986	13	49027225	49027225	A	T	PASS	RB1	NM_000321.3	18	c.1792A>T	p.Asn598Tyr	missense_variant				41	0.0
	EBPL(3.9%)	exon4,c.516del,p.F172fs	0.039	0.01	1726|91	217|1	0.03466	2952|106	13	50235208	50235209	TA	T	multiallelic,panel_of_normals,slippage	EBPL	NM_032565.5	4	c.516del	p.Phe172fs	frameshift_variant				41	0.0
	EBPL(4.0%)	exon4,c.516dup,p.N173*	0.04	0.078	1726|99	217|20	0.04466	2952|138	13	50235208	50235209	TA	TAA	multiallelic,panel_of_normals,slippage,suspected_bg	EBPL	NM_032565.5	4	c.516dup	p.Asn173*	frameshift_variant&stop_gained				42	0.0
	IRS2(52.0%)	exon1,c.3219C>G,p.T1073=	0.52	0.167	16|14	5|0	0.51429	17|18	13	110435182	110435182	G	C	PASS	IRS2	NM_003749.3	1	c.3219C>G	p.Thr1073=	synonymous_variant				33	0.0
	BLM(2.1%)	exon7,c.1544del,p.N515fs	0.021	0.022	7033|201	2320|57	0.02310	20430|483	15	91304138	91304139	GA	G	multiallelic,normal_artifact,panel_of_normals,slippage	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome	40	0.0
	BLM(2.0%)	exon7,c.1544dup,p.N515fs	0.02	0.019	7033|199	2320|57	0.02872	20430|604	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome	41	0.0
	CHD2(3.3%)	exon29,c.3734del,p.K1245fs	0.033	0.023	585|28	146|6	0.03359	863|30	15	93540315	93540316	GA	G	multiallelic,normal_artifact,panel_of_normals,slippage	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Pathogenic/Likely_pathogenic		Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_provided	48	0.0
	CHD2(4.3%)	exon29,c.3734dup	0.043	0.053	585|38	146|6	0.04851	863|44	15	93540315	93540316	GA	GAA	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734dup		splice_donor_variant&intron_variant	Conflicting_interpretations_of_pathogenicity	Likely_benign(1),Pathogenic(1)	Developmental_and_epileptic_encephalopathy_94	37	0.0
	CHD2(5.3%)	exon33,c.4173dup,p.Q1392fs	0.053	0.07	236|14	43|3	0.05919	302|19	15	93545433	93545433	G	GA	normal_artifact,panel_of_normals,slippage,suspected_bg	CHD2	NM_001271.4	33	c.4173dup	p.Gln1392fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(4),Uncertain_significance(1)	CHD2-Related_Disorder|Autistic_behavior|Seizures|Developmental_and_epileptic_encephalopathy_94|Complex_neurodevelopmental_disorder|not_provided	41	0.0
	IGF1R(2.0%)	exon4,c.962G>A,p.C321Y	0.02	0.02	363|6	71|0	0.01336	443|6	15	99439994	99439994	G	A	PASS	IGF1R	NM_000875.5	4	c.962G>A	p.Cys321Tyr	missense_variant				60	0.0
-	CDH1(0.3%)	exon3,c.377del,p.P126fs	0.003239	0.00413	8570|50	2132|16	0.00416	24631|103	16	68835780	68835781	GC	G	normal_artifact,panel_of_normals	CDH1	NM_004360.5	3	c.377del	p.Pro126fs	frameshift_variant	Pathogenic		Hereditary_diffuse_gastric_cancer|not_provided	39	0.0
	PLCG2(4.5%)	exon29,c.3262G>T,p.E1088*	0.045	0.047	149|10	26|0	0.07500	185|15	16	81972469	81972469	G	T	orientation,panel_of_normals,strand_bias,background	PLCG2	NM_002661.5	29	c.3262G>T	p.Glu1088*	stop_gained				14	0.0
	PLCG2(5.9%)	exon29,c.3269_3279delinsCTGTAGACGAC,p.C1090_E1093>SVDD	0.059	0.04	163|9	27|0	0.05298	143|8	16	81972476	81972486	GTGGAGCCGAG	CTGTAGACGAC	orientation,panel_of_normals,strand_bias	PLCG2	NM_002661.5	29	c.3269_3279delinsCTGTAGACGAC	p.Cys1090_Glu1093delinsSerValAspAsp	missense_variant				20	0.0
-	TP53(38.9%)	exon9,c.949del,p.Q317fs	0.389	0.002206	2645|1684	1018|3	0.38350	5715|3555	17	7576896	7576897	TG	T	PASS	TP53	NM_000546.6	9	c.949del	p.Gln317fs	frameshift_variant	Pathogenic		Neoplasm_of_ovary|Li-Fraumeni_syndrome	36	0.0
	ERBB2(0.3%)	exon7,c.785G>A,p.G262D	0.003003	0.001205	4934|15	989|0	0.00298	11700|35	17	37866618	37866618	G	A	PASS	ERBB2	NM_004448.4	7	c.785G>A	p.Gly262Asp	missense_variant				38	0.0
	MYOM1(2.1%)	exon4,c.568_603del,p.T190_Q201del	0.021	0.00501	919|19	216|1	0.00185	540|1	18	3188913	3188949	ACTGCTTGGATGCCGTGGACTGCTTAGATGCCGTGGT	A	clustered_events,panel_of_normals	MYOM1	NM_003803.4	4	c.568_603del	p.Thr190_Gln201del	conservative_inframe_deletion	Likely_benign		Hypertrophic_cardiomyopathy	27	0.0
	SMARCA4(50.0%)	exon9,c.1524T>C,p.H508=	0.5	0.159	26|22	7|0	0.38333	37|23	19	11105608	11105608	T	C	germline,panel_of_normals	SMARCA4	NM_001128849.3	9	c.1524T>C	p.His508=	synonymous_variant	Benign		Rhabdoid_tumor_predisposition_syndrome_2|Mental_retardation,_autosomal_dominant_16|Hereditary_cancer-predisposing_syndrome|Coffin-Siris_syndrome|not_specified	34	0.0
